FY4/21 1Q
IR PRESENTATION

September 2020

Results Overview© 2020 AIN HOLDINGS INC. All Rights Reserved.

1

Consolidated P/L
Net sales decreased 1.4% YoY and 0.6% against the plan due to the impact of the COVID-19 outbreak,despite the contribution of 6 stores opened(including M&A) in this fiscal year and store opened in previous
year. Ordinary income declined 60.7% YoY due to net sales lower than forecast and up 47.7% against theplan due to reduction of administrative expense.
(¥ million)

Net sales
Gross profit% of net sales

FY4/20 1Q
results

72,461
11,49015.9

FY4/21 1Q
plan

71,90010,032
14.0

FY4/21 1Q
results

YoYchangeYoYchange(%)

Vs plan
(%)

(998)
(1.4)
71,4639,819 (1,671) (14.5)(0.6)+1,087 +14.4

(4.0)

13.7

(2.1)

7,568

9,012

8,655

3,921

1,020

1,164 (2,757) (70.3) +14.1

4,212

1,120

1,654 (2,558) (60.7) +47.7

Profit attributable toowners of parent

2,240

571

846 (1,394) (62.2) +48.2

Earnings per
share(¥)

63.24

16.12

23.90 (39.34) (62.2) +48.3

SG&A expenses% of net sales

Operating income% of net sales

Ordinary income% of net sales

10.4
5.4
5.8
3.1

% of net sales

12.5
1.4
1.6
0.8

12.1

1.6
2.3
1.2

Figures in the table are rounded down
© 2020 AIN HOLDINGS INC. All Rights Reserved.

2

Dispensing Pharmacy Business (Consolidated)
Net sales decreased 3.0% YoY and 0.7% against the plan due to the impact of the COVID-19 outbreak.
Segment income declined 28.0% YoY due to decrease of net sales and up 2.6% against the plan due toreduction of administrative expense.
(¥ million)

Net sales
Gross profit% of net sales

FY4/20 1Q
results

64,8008,409
13.0

FY4/21 1Q
plan

FY4/21 1Q
results

YoYchangeYoYchange(%)

Vs plan(%)

63,3206,890

62,888 (1,912) (3.0) （0.7)
6,661 (1,748) (20.8) (3.3)

10.9

10.6

SG&A expenses

3,738

3,622

3,537

(5.4)

(2.3)

Operating income

4,671

3,268

3,124 (1,547) (33.1)(4.4)

Segment income

4,804

3,372

3,458 (1,346) (28.0)+2.6

Number ofpharmacies

1,120

1,083

1,081

(0.2)

% of net sales% of net sales% of net sales

5.8
7.2
7.4

5.7
5.2
5.3

5.6

(201)

5.0
5.5

(39)

(3.5)

Figures in the table are rounded down
Segment income is adjusted to ordinary income shown on the consolidated statements of income
Prescription volume: (14.0)% YoY
Average prescription price: +12.6% YoY© 2020 AIN HOLDINGS INC. All Rights Reserved.

3

Cosmetic and Drug Store Business (Consolidated)
Net sales declined 34.5% YoY and up 2.3% against the plan due to temporarily closed or shorted opening
hours at many stores, despite the group has opened 3 stores in this fiscal year. Segment loss was ¥292
million due to net sales declined.
(¥ million)

FY4/20 1Q
results

FY4/21 1Q
plan

YoYchangeYoYchange(%)

Vs plan(%)

Gross profit

6,560
2,495

SG&A expenses

2,277

2,072

2,014

(263) (11.6)

Operating income

217

(460)

(425)

(642)

-

-

Segment income

230

(460)

(292)

(522)

-

-

Number of stores

55

64

64

+9

+16.4

0.0

Net sales% of net sales% of net sales% of net sales% of net sales

38.0

34.7
3.3
3.5

4,200
1,612

FY4/21 1Q
results

38.4

49.3
-

4,296 (2,264) (34.5)
1,589(906) (36.3)

(1.4)
(2.8)

37.0

46.9
-

+2.3

Figures in the table are rounded down
Segment income is adjusted to ordinary income shown on the consolidated statements of income
Number of customers: (31.7)% YoY
Average spending per customer: (4.1)% YoY© 2020 AIN HOLDINGS INC. All Rights Reserved.

4

Consolidated B/S
Net cash became ¥36,719 million and shareholders’ equity ratio became 58.4%. We are maintaining asound financial structure even during the COVID-19 outbreak.
(¥ million)(¥ million)

End-FY4/21 1Q

End-FY4/20
AssetsCurrent assets
Cash on hand andin banks

Fixed assets

AssetsLiabilities

87,802 Current liabilities
46,321

105,632

74,700

Short-term debt
Lease obligations

3,642
193

Long-term
liabilities

7,747

105,405

Short-term debt
Lease obligations

3,171
165

Long-term
liabilities

7,318

Long-term debt
Lease obligations

1,961
111

111,003

Deferred
assets4

Total net assets

109,907

193,451

Total assets

188,225

Total liabilities
and net assets

188,225

Long-term debt
Lease obligations

2,432
154

Deferred
assets15

Total net assets

193,451

Total liabilities
and net assets

Shareholders’ equity
ratio(%)

Fixed assets

42,12870,99941,30342,123

Net cashCash on hand andin banks

82,815 Current liabilities

Goodwill

Goodwill

Total assets

Current assets

Liabilities

39,89957.3

Net cash
Shareholders’ equity
ratio(%)

36,71958.4

Figures in the table are rounded down
Net cash = Cash on hand and in banks – Interest-bearing debt (Long-and short-term debt + Lease obligations)© 2020 AIN HOLDINGS INC. All Rights Reserved.

5

Assets
The balance of total assets decreased ¥5,226 million from the end of the previous fiscal year due todecrease of cash on hand and in banks and accounts receivable.
(¥ million)

End-FY4/20 1Q

End-FY4/20

End-FY4/21 1Q

Change40,753
15,94013,897
83,311
16,355
10,484487

46,321
13,653
15,32287,802
16,60910,960272

42,128
12,204
15,58882,815
16,521
10,868208(4,193)(1,449)+266(4,987)
(88)
(92)
(64)

30,21630,87430,808(66)

44,216
6
46,6301,820
4,276
15,07842,123
5
44,916
2,295
4,211
19,14441,303
4
44,2992,296
4,196
19,154

(820)
(1)
(617)
+1
(15)
+10

26,336

29,84130,297+456

Total assets

103,184
48
186,543

105,632
15
193,451

105,405
4
188,225(227)(11)(5,226)

Figures in the table are rounded down

Change:End-FY4/21 1Q compared with End-FY4/20

Cash on hand and in banks
Notes and accounts receivable
Inventories
Total current assets
Buildings and structures,net
Land
Lease assets
Total property,plant andequipment
Goodwill
Lease assets
Total intangible fixed assets
Investments in securities
Deferred tax assets
Deposits and guarantees
Total investments and otherassetsTotal fixed assets
Total deferred assets

Capital expenditures (Property, plant and equipment and intangible fixed assets + Deposits and guarantees) totaled ¥1,351 million© 2020 AIN HOLDINGS INC. All Rights Reserved.

6

Liabilities and Net Assets
The balance of liabilities decreased ¥4,129 million from the end of the previous fiscal year due todecrease of accounts payable.
(¥ million)

End-FY4/20 1Q

46,194
5,045
286

Accounts payable
Short-term debt
Lease obligations(1,853)(471)(28)

70,999(3,701)

10,421
82,3897,747
82,447

7,318
78,318(429)(4,129)104,212104,154

111,151
111,003

110,050
109,907(1,101)(1,096)

186,543

193,451

188,225(5,226)5,014
330

Lease obligations
Total long-term liabilities
Total liabilities

21,89420,50061,818

Common stock
Capital surplus
Retained earnings

Total liabilities and net
assets45,334
3,171
165

Change74,700Long-term debt

Total net assets

47,187
3,642
193

End-FY4/21 1Q

71,967

Total current liabilities

Total shareholders’ equity

End-FY4/20

2,432
154

21,89420,50068,7581,961
111

21,89420,50067,656(471)(43)(1,102)

Figures in the table are rounded down
Change : End-FY4/21 1Q compared with End-FY4/20© 2020 AIN HOLDINGS INC. All Rights Reserved.

7

FY4/21 Plan (Consolidated)
The group forecasts net sales for the fiscal year ending April 30, 2021 increase 6.3% and ordinary
income decrease 10.8% YoY by open new stores (50 dispensing pharmacies and 12 cosmetic anddrug stores).
（¥ million）

FY4/19results

FY4/20results

FY4/21plan

YoYchangeYoYchange (%)

275,596
45,363292,615
46,861

311,000 +18,385
51,070 +4,209

29,29530,79336,470 +5,677+18.4

16,067

16,06814,600 (1,468)(9.1)

16,637

16,822

15,000 (1,822)(10.8)

9,029

8,200

(979)

(10.7)% of net sales

3.3

9,179

Earnings per
share(¥)

254.87259.11231.46 (27.65)(10.7)

55.00

55.00

55.00

Net sales
Gross profit% of net sales

SG&A expenses% of net sales

Operating income% of net sales

Ordinary income% of net sales

Profit attributable toowners of parent

Annual dividend (¥)

16.5
10.6

5.8
6.0

Figures in the table are rounded down
© 2020 AIN HOLDINGS INC. All Rights Reserved.

16.0
10.5

5.5
5.7
3.1

16.4
11.7

4.7
4.8
2.6

-

+6.3
+9.0

0.0

YoY change :FY4/21 plan compared with FY4/20 results
8

Review
Revision of 2020
Growth strategy© 2020 AIN HOLDINGS INC. All Rights Reserved.

9

Review© 2020 AIN HOLDINGS INC. All Rights Reserved.

10

Review（YoY）
Net sales declined 1 billion and ordinary income decreased 2.6 billion due to the impact of the COVID-19
outbreak, despite the contribution of stores opened(including M&A) in previous year, but decline in thenumber of prescriptions and temporarily closed or shortened the opening hours of many cosmetic anddrug stores.

Net sales¥72.4 billion

Dispensing
Pharmacy

Ordinary income¥(1.0) billion¥71.4 billion
Dispensing
PharmacyStore opened +¥1.8billion
in last FY+¥0.3billion
New
stores¥(2.7)billion
Existing
stores¥(1.3)billion
Others¥(1.9) billion¥64.8 billion¥62.9 billion

Cosmetic andDrug Store¥6.5 billion

Cosmetic andDrug Store¥4.3 billion

Others ¥1.1 billion

Others ¥4.2 billion

FY4/20 1Q
results

FY4/21 1Q
results© 2020 AIN HOLDINGS INC. All Rights Reserved.

Stores opened+¥0.4billion
in last FYExisting¥(2.3)billion
storesClosing¥(0.3)billion
stores¥(2.2) billion

Retail shop+¥3.1billion+¥3.1 billion¥(2.6) billion¥4.2 billion
Dispensing
Pharmacy¥1.6 billion¥4.8 billion

Dispensing
Pharmacy
Cosmetic andDrug Store¥0.2 billion

Others ¥(0.05) billion¥3.4 billion

Net sales
declined ¥(2.6)billion¥(2.6) billion

Cosmetic andDrug Store¥(0.3) billion

Administrative
expense¥(0.75) billion

Others ¥(0.3) billion

FY4/20 1Q
results

FY4/21 1Q
results

Administrative
expense¥(1.2) billion
11

Review（Vs plan）
Net sales fell 0.5 billion against the plan due to the impact of the COVID-19 outbreak, while ordinary
income increased 0.5 billion against the plan due to cost reduction.

Net sales¥71.9 billion

Ordinary income¥(0.5) billion+¥0.5 billion¥71.4 billion

Dispensing
Pharmacy

Dispensing
Pharmacy

Existing
stores¥63.3 billion¥62.9 billion

Cosmetic andDrug Store¥4.2 billion

Cosmetic andDrug Store¥4.3 billion

Existing
stores+¥0.2billionStore
opened¥(0.05)billion
in last FYOthers¥(0.05)billion

Others ¥4.4 billion

Others ¥4.2 billion

FY4/21 1Q
plan

FY4/21 1Q
results¥(0.4)billion¥(0.4) billion¥1.1 billion
Dispensing
Pharmacy

Dispensing
Pharmacy¥3.3 billion¥3.4 billion

Cosmetic andRetail shop
Drug Store¥(0.2)billion
OthersCosmetic andDrug Store¥(0.3) billion+¥0.1 billion¥(0.2) billion¥(0.4) billion

Others ¥(0.4) billion

Administrative
expense¥(1.4) billion© 2020 AIN HOLDINGS INC. All Rights Reserved.

¥1.6 billion

FY4/21 1Q
plan

Net sales¥(0.05)billion
costs¥(0.15)billion

SG&A+¥0.7billion
expenses+¥0.5 billion

Others ¥(0.3) billion

Administrative
expense¥(1.2) billion

FY4/21 1Q
results

12

Revision of 2020

© 2020 AIN HOLDINGS INC. All Rights Reserved.

13

Responsive to revision of 2020
Object: 1,060 existing stores
 Community support system premiums

 Basic dispensing fee

Stores

1,000
500
0

2（26pts）

3-Ⅱ（16pts）

SP.（9pts）

434

427

448

449

9

10

7

7

597

602

582

581

20

21

23

23

4/19

3/20

4/20

7/20

No Premiums

1,000Stores1（42pts）

500

500

383
319

0

1(15pts)2(22pts)3(28pts)

546

575

597

206

252
108
154

248
92
145

234
96
133

4/19

3/20

4/20

7/20

152

355

363

371

731

705

697

689

4/19

3/20

4/20

7/20

 Transition of average of GE premiums
（pts）
25.0
GE averagepremiums

Stores

1,000

329

0

 GE premiums
No Premiums

Community support system premiums(38pts)

20.0
15.0

All

3 main subsidiaries

Other

22.4

18.9
17.8
15.7

21.4
15.8

19.3

14.8
12.2

10.0
3/18

4/18

1/19

4/19

4/20

7/20

Average of GE premiums per a reception© 2020 AIN HOLDINGS INC. All Rights Reserved.

GE drugs share (volume)：82.4%（Av. of 5/20-7/20）

14Growth strategy© 2020 AIN HOLDINGS INC. All Rights Reserved.

15

Growth Strategy
Considering the institutional changes and deregulation in future, the Group continues to open highpotential stores and reinforcing the Group’s business base.

■ Top-line
Expanding of business by active new store openings inprime location and by secure M&As
AIN Pharmacy DOKKYOIDAI■ Reinforcing the Group’s business base

To rebuild the Group’s business base by improve the operational
efficiency and logistics reform utilizing ICT and Group brandbuilding■ Recruiting and training human resources,

Strengthening the function of pharmacies

Recruiting activity and development of human resources
with the energy of the entire company, and enhancing
Primary Care and specialized functions■ Expansion of ainz & tulpe
Improve the ratio of original brands and margin by continued toopen ainz & tulpe in the major urban area and by implementing
measures to raise brand visibility in urban markets© 2020 AIN HOLDINGS INC. All Rights Reserved.

ainz & tulpe Daimaru Kyoto
16Top-line
The group opened 6 stores including M&A, and closed 12 stores during the FY4/21 1Q.
■ Total number of stores

1,145 (Dispensing pharmacy:1,081、Cosmetic and drug store:64)

Opening
ClosedFY4/21

FY4/21 1Q■ PlanPlan

Results

Plan

4

3

50

Organic

1

1

28

M&A

3

2

22

Cosmetic anddrug store

3

3

12

Total

7

6

62

9

10

18

2

2

2

11

12

20

Dispensing
Pharmacy

Dispensing

Pharmacy
Cosmetic anddrug store

Total() initial plan

■ Transition of dispensing pharmacies
Organic
M&A

EV/EBITDA ratio

ClosedSold

No. of total stores

Hokkaido
119
Koshinetsu
108
Chugoku,
Shikoku
93

Tohoku168

Hokuriku
24

Kyusyu, Okinawa
43

Kanto
376

Kinki
130

Tokai
84
End-FY4/21 1Q

FY4/13

FY4/14

FY4/15

FY4/16

FY4/17

FY4/18

FY4/19

38

36

40

32

27

25

23

14

1

38
5.09

26
3.94

119
4.77

110
5.37

182
5.50

11
3.96

134
4.88

6
3.71

2
3.45

10
560

6
1
616

21
1
754

15
1
881

24
2
1,066

73
32
1,029

54
30
1,132

64
42
1,088

10
8
1,081

EV/EBITDA ratio=EV(Purchase price)/EBITDA(Operating income + Depreciation and amortization)© 2020 AIN HOLDINGS INC. All Rights Reserved.

FY4/20 FY4/21 1Q

17

M&A
The Group have only acquired 2 dispensing pharmacies during the period, as we continue tofocus on investing in better deals from previous fiscal year, but we are actively collecting
information.
■ M&A criteria
Our targets

M&A criteriaStore size

EV/EBITDA
ratio

ProfitAnnual net sales
more than ¥200 million

5 - 7 times

Contribute from next fiscal year

Annual net sales
more than¥200 million
Dispensing
pharmacymarket¥3.1 trillion¥7.7 trillion

Annual net sales
less than¥200 million¥4.6 trillion
Risk

Onsite pharmacy
Compliance issues
Estimated by Recent trend of national dispensing
medical expenses(2019) from Ministry of Health,
Labor and Welfare© 2020 AIN HOLDINGS INC. All Rights Reserved.

18

Reinforcing the Group’s business baseWe aim to reinforcing the Group’s business base by actively investing in ICT, logistics, and Groupbrand building that will support our future growth.
Investment projects

Subject■ ICT・Logistics

Securing specialized
human resources
Collecting andutilizing data

Proactively hiring people with expertise in IT and logistics
Creating a company-wide database for accounting, KPI, human resources, store
sales, etc. to achieve faster decision making

Raising theoperating efficiency• Introduced RPA robots, automation of routine work
• Streamlining various inquiries and accumulating know-how by introducing ITSM

Network, Security

Rebuilding the network systems and strengthening security to prepare for future
growthImproving thecustomer services

Utilizing ICT like app for improving customer satisfaction• Renewal of patient medication notebook app, etc.
• Launched official ainz & tulpe app and EC website as well as expand
merchandise lineup

Logistic reform

Building efficient and reliable logistics system according to group scale expanding• Running the Kasai logistic center of WSS• Started operation logistics center for retail business in the Kansai and Kanto area

■ PR
EnhancingGroup brand© 2020 AIN HOLDINGS INC. All Rights Reserved.

Group branding for stakeholders, recruiting and business development• Launch a nationwide TV advertising campaign, for both business• Rebrand store’s signboards as “AIN Pharmacy”
19Recruiting
In April 2020, new 560 pharmacists has joined our group. For Strengthening the function of pharmacies
such as home-based healthcare and the primary care services, and for large scale new opening, securinga pharmacist through recruiting and training human resources is a major strength for the Group. We aim
to hire roughly the same number in fiscal 2021 to prepare for new store openings including M&A.
■ The transition of No. of national examination passers and new qualified pharmacists in AIN Group2012（People）

No. of newly qualified
pharmacists hired in
AIN Group
No. of pharmacists’national examination
passers (pass rate)
Rate of newly qualified
pharmacists hired in
AIN Group

2013

2014

2015

2016

2017

2018

2019

2020

2021(Plan)

189

251

251

229

375

307

279

257

560

550

8,641

8,929

7,312

9,044

11,488

9,479

9,584

10,194

9,958

-

2.5%

3.3%

3.2%

5.6%

-

（88.3%） （79.1%） （60.8%） （63.2%） （76.9%） （71.6%） （70.6%） （70.9%） （69.6％）

2.8%

2.2%

（5.7%）（7.0%）

3.4%（8.0%）（8.0%） （11.7%） （10.0%）

2.9%（8.0％）

2.5%（5.8%）（-）

Estimates : based on the result in AIN Group, and data from the Ministry of Health, Labor and Welfare, Council on Pharmaceutical Education.

（People）
1,200

General staff

Pharmacists

No. of newly-hired employees

1,000
800
560

600
400
200
0

375
229

307

279

189
47

251

251

53

28

93

173

174

152

2012

2013

2014

2015

2016

2017

2018

© 2020 AIN HOLDINGS INC. All Rights Reserved.

550

257
277
2019

392
2020

500

2021
（Plan）

20

The function of pharmacies
In terms of functions such as promotion of GE use, home-based health care and primary careservices, which have been demanded by the country and patients, we have accumulated highachievements compared with pharmacies nationwide.
 Comparison of results (As of March 2020)
Basic dispensing fee
No. ofstores

１(42)

２(26)

OthersCommunity
supportsystempremiums

GE drugs share
Under
80%

(38)

58,995

Japan
%

AIN
Group

Over
80%

No. ofNo. ofHome-based
notification
health careof primaryOver 10caretimes perpharmacists
year

17,338 25,558 33,437 32,082 17,712

49,210

1,673

8,112

83.4

2.8

13.8

35.2

43.3

56.7

54.4

30.0

438

9

639

354

269

817

926

807

1,086

40.3

0.8

当社調べ %地域支援は基本料１の薬局数に対する構成比

58.8

80.8

24.8

75.2

85.3

74.3

The Group’s own research. % of community support system premiums is from the No. of stores that applicable to BDF 1.

Notification of primary care pharmacists
Japan

54.4

Japan

AIN Group

85.3

0

20

40

© 2020 AIN HOLDINGS INC. All Rights Reserved.

60

Home-based health care Over 10 times per year

80

100（%）

30.0

AIN Group

74.3
0

20

40

60

80（%）
21

Revised Pharmaceuticals and Medical Devices Act
Pharmaceuticals and Medical Devices Act has been revised on September 1, 2020. The group
continues Strengthening the function of pharmacies.
Content
Required to followup during
medication period

Date ofimplementation

Pharmacists will be required as necessary to ascertain drug treatment
and provide guidance at times other than the point of prescription.
Required to provide patient’s drug information to other medical institutions.
Sep.1, 2020

Online drug
guidance

Exceptions to face-to-face drug guidance will be allowed if the properuse of drug can be ensured via video phone or other.
Specific rules will be defined in the ministerial ordinance.

Pharmacy function
certification system “Community liaison pharmacy”, “specialized medical institutions
pharmacy” will be certified and renewed every year.
by prefectural
governors
Ensuring
governanceClarify the officers responsible for pharmaceutical Affairs Law, required
to establish a system for legal compliance, including the appointment of asupervising pharmacist with the necessary skills and experience.

Digitization of
medical package
insertEliminate the inclusion of medical package insert, provide informationelectronically in principle.

Aug.1, 2021

Excerpted by the Group© 2020 AIN HOLDINGS INC. All Rights Reserved.

22

Online drug guidance
Online drug guidance became available nationwide on September 1. Since special measures (0410
government announcement) for preventing the spread of COVID-19 are still effective, it have to
explain carefully to those who wish to use this service.
■ History of online drug guidance
5/7/1830/9/19

19/12/19

28/2/20

10/4/20

1/9/20AIN Group
first case inJapan (Aichi)
to provide
online drug
guidance

Partialrevision of
the National
Strategic
SpecialZones ActAIN Group
Apply for registration
as online drug
guidance provider in
the NSSZ(Chiba)

Special measures thatenable drug guidance
using telephones andinformation
communication devices

Easerequirement
for Special
measures(0410 GA.)

Revised PMD
Act, Online
drug guidance
becameavailable
nationwide■ Difference between special measures（0410 GA.）and online drug guidanceSpecial measures（0410 GA.）

Online drug guidance

Medicalexamination

・Available from first medical examination
・Via telephone is allowed

・Not allowed for first medical examination
・Must use video phone

Prescription

・Copy(FAX) of prescription is also allowed
・Medical institution is allowed to send canoriginal script to pharmacy at a later date・Should bring the original script（FAX are not allowed）
・Medical institution is allowed to send canoriginal script to pharmacy

・Drug guidance can be provide via
telephone or video phone・Must use video phone
・Only the pharmacist who has provided drug
guidance and same drug face-to-face
・Patient’s consent for frequency of face-to-facevisiting and type of drug is required throughmake a schedule in advanceDrugguidance
TargetOther

Excerpted by the Group© 2020 AIN HOLDINGS INC. All Rights Reserved.

23

Expansion of ainz & tulpe①
ainz & tulpe
new store opening in FY4/21

12Stores

Sapporo ※Planning

Tohoku ※Planning※Other 3 stores are under planning

Tokyu plaza totsuka（Scheduled to open in Sep 18, 2020）
Daimaru Kyoto(5/6/2020)
Daimaru Umeda(5/6/2020)

Hibiya chanter （10/7/2020)
Tokyo ※Planning

Kyushu ※Planning© 2020 AIN HOLDINGS INC. All Rights Reserved.

Sanste okayama（Scheduled to open in Sep 16, 2020）24

Expansion of ainz & tulpe②
The group launched the official ainz & tulpe app which can also manage points in October 2019 andan EC website in May 2020. In this August, official app and EC website were linked to improved
customer satisfaction by reducing sales opportunity loss and optimized store inventory.
■ The official ainz & tulpe app
・point card functions
・coupons
・shop list・purchase history
・new productinformation
・advertising space etc.

Not only for improve
convenience for customers but
also to increase net sales byrunning the app.

■ The official EC website ”ainz & tulpe WEBSTORE”
・Original brand page・new opening store
information
・Point and purchasehistory etc. can link
to app© 2020 AIN HOLDINGS INC. All Rights Reserved.

Due to the impact of COVID-19,
demand is increasing on EC
website and the Group aims toincrease net sales byconnectivity the app and EC.

25

FY4/21 Plan (Consolidated)
The group forecasts net sales for the fiscal year ending April 30, 2021 increase 6.3% and ordinary
income decrease 10.8% YoY by open new stores (50 dispensing pharmacies and 12 cosmetic anddrug stores).
（¥ million）

FY4/19results

FY4/20results

FY4/21plan

YoYchangeYoYchange (%)

275,596
45,363292,615
46,861

311,000 +18,385
51,070 +4,209

29,29530,79336,470 +5,677+18.4

16,067

16,06814,600 (1,468)(9.1)

16,637

16,822

15,000 (1,822)(10.8)

9,029

8,200

(979)

(10.7)% of net sales

3.3

9,179

Earnings per
share(¥)

254.87259.11231.46 (27.65)(10.7)

55.00

55.00

55.00

Net sales
Gross profit% of net sales

SG&A expenses% of net sales

Operating income% of net sales

Ordinary income% of net sales

Profit attributable toowners of parent

Annual dividend (¥)

16.5
10.6

5.8
6.0

Figures in the table are rounded down
© 2020 AIN HOLDINGS INC. All Rights Reserved.

16.0
10.5

5.5
5.7
3.1

16.4
11.7

4.7
4.8
2.6

-

+6.3
+9.0

0.0

YoY change :FY4/21 plan compared with FY4/20 results
26Inquiries related to this presentation should be addressed to

AIN HOLDINGS INC.
Corporate Planning Division
TEL(81)11-814-0010
FAX(81)11-814-5550
https://www.ainj.co.jp/
This document may not be reproduced or distributed to any third party without
prior approval of AIN HOLDINGS INC. This document has been prepared for
information purpose only and does not form part of a solicitation to sell orpurchase any securities. Information contained herein may be changed orrevised without prior notice. This document may contain forecastingstatements as to future results of operations. No forecast statement can be
guaranteed and actual results of operations may differ from those projected.

© 2020 AIN HOLDINGS INC. All Rights Reserved.

27